21. Mitochondrial disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 108 / Drugs : 107 - (DrugBank : 35) / Drug target genes : 48 - Drug target pathways : 110
| Other names | Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; | ||
|---|---|---|---|
| Disease group | Metabolic diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
1,672 patients Age distribution
 💬 |
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Notice（R7.1.16） (pdf), Notice（R7.2.26） (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 8-4-50. Pyruvate dehydrogenase complex deficiency | ||
| 8-4-51. Pyruvate carboxylase deficiency | |||
| 8-4-52. Fumarase deficiency | |||
| 8-4-53. Succinyl-CoA ligase deficiency | |||
| 8-4-54. Mitochondrial respiratory chain disorders | |||
| 8-4-55. Mitochondrial DNA depletion syndrome | |||
| 8-4-56. Diseases due to mitochondrial DNA mutation | |||
| 8-4-57. Diseases due to mitochondrial DNA deletion | |||
| 8-4-58. Other mitochondrial diseases | |||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | - | ||